| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | BIOTECNOLOGÍA | 15,480000 | 31/10/2025 | 36,39% | 60,75% | **** |
| GCO ACCIONES, FI | RV ESPAÑA | 115,846732 | 28/10/2025 | 36,33% | 97,17% | ** |
| BNY MELLON BRAZIL EQUITY FUND EURO A (ACC) | RVI LATINOAMÉRICA | 1,585500 | 31/10/2025 | 36,32% | 13,62% | *** |
| CT (LUX) GLOBAL TECHNOLOGY AEH EUR | TMT | 127,929800 | 31/10/2025 | 36,25% | 132,09% | ***** |
| LO FUNDS - EMERGING HIGH CONVICTION SYST. NAV HDG (CHF) N CAP | RVI EMERGENTES | 17,105161 | 30/10/2025 | 36,22% | 73,87% | **** |
| GOLDMAN SACHS GREATER CHINA EQUITY R CAP USD | RVI CHINA | 320,711442 | 31/10/2025 | 36,15% | 98,93% | ***** |
| GOLDMAN SACHS GREATER CHINA EQUITY R DIS USD | RVI CHINA | 320,296001 | 31/10/2025 | 36,15% | 96,24% | ***** |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI EMERGENTES | 103,740000 | 30/10/2025 | 36,11% | 51,56% | **** |
| AXA WORLD FUNDS-AI & METAVERSE G CAP EUR HEDGED | TMT | 183,160000 | 31/10/2025 | 36,10% | 125,98% | ***** |
| DWS INVEST BRAZILIAN EQUITIES FC | RVI LATINOAMÉRICA | 187,720000 | 31/10/2025 | 36,04% | -1,05% | ** |
